HIGHLIGHTS
- who: Landon Haslem and collaborators from the University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA have published the Article: p66Shc in Cardiovascular Pathology, in the Journal: Cells 2022, 11, x FOR PEER REVIEW of /2022/
- what: Lastly, p66Shc is an oxidoreductase that directly contributes to pro-apoptotic mitochondrial ROS activity and indirectly to cytoplasmic ROS levels, which will be discussed in detail below . p66hcmediated ROS activity plays a central role in cardiovascular pathology through a variety of interacting pathways and is still emerging as a research field and potential therapeutic target in cardiovascular . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.